Jiang Liu

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia

Aviva C. Krauss, Xin Gao, Liang Li et al. · Clinical Cancer Research · 2018 · 327 citations · Full text

Medicine, Oncology, Pharmacology +17

FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia

Kelly J. Norsworthy, Chia‐Wen Ko, Jee Eun Lee et al. · The Oncologist · 2018 · 259 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2

Kushal Suryamohan, Devan Diwanji, Eric Stawiski et al. · Communications Biology · 2021 · 233 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Biology +17

FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1

Preeti Narayan, Sakar Wahby, Jennifer Gao et al. · Clinical Cancer Research · 2020 · 182 citations

Medicine, Oncology, Pharmacology +17

FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma

Sandra J. Casak, Martha Donoghue, Lola A. Fashoyin‐Aje et al. · Clinical Cancer Research · 2020 · 178 citations

Pharmacy, Pharmacology, Pharmacotherapy +15